3-(4-Fluorophenyl)-1-isopropyl-1H-indole

We are 3-(4-Fluorophenyl)-1-isopropyl-1H-indole CAS:93957-49-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-(4-Fluorophenyl)-1-isopropyl-1H-indole
CAS.NO:93957-49-4
Synonyms:3-(4-Fluorophenyl)-1-isopropyl-1H-indole
1-Isopropyl-3-(4-fluorophenyl)-indole
3-(4-fluorophenyl)-1-propan-2-ylindole
3-(4-Fluorophenyl)-1-(propan-2-yl)-1H-indole
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 389.6±25.0 °C at 760 mmHg
Melting Point 96-97°C
Molecular Formula C17H16FN
Molecular Weight 253.314
Flash Point 189.4±23.2 °C
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.573
 
Specification:
Appearance:Off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Fluvastatin(CAS:93957-54-1).

3-(4-Fluorophenyl)-1-isopropyl-1H-indole


Related News: Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.2,4-dicloro-5- (trifluorometil) pirimidina CAS:3932-97-6 In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth.4-Methoxyphenylboronic Acid CAS:45713-46-0 Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.369-35-7 Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.Retrogenix holds two Queen’s Awards for Enterprise, the UK’s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA.

Related Products
Product Name
Dolutegravir Sodium View Details
5-Fluoro-2-oxindole View Details
(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole View Details
Furfural manufacturer 3-trimethoxysilylpropyl acetate manufacturer (5-formylfuran-2-yl)boronic acid manufacturer 1,5-Dibromopentane manufacturer 2-Chloro-5-hydroxymethylpyridine manufacturer